Abbott Labs. - Apr., p. 102; Oct., p. 291
Abt Associates, Inc. - Feb., p. 43
Academic Press - Oct., p. 299
Activated Cell Therapy - Sep., p. 268
Adatomed GmbH - Dec., p. 363
Advanced Technology Program - Nov., p. 332
Agouron Pharmaceuticals, Inc. - Feb., p. 36; Mar., p. 70; Oct., p. 291
Agracetus, Inc. - Nov., p. 332; Dec., p. 362
AIDS Action Baltimore, Inc. - Sep., p. 262
AIDS Clinical Trials Groups - May, p. 135
AIDS Project Los Angeles - Feb., p. 44
AIDS Vaccine Evaluation Units (AVEUs) - July, p. 204
Ajinomoto Co., Inc. - Feb., p. 41; Apr., p. 97
Allelix Biopharmaceuticals Inc. - May, p. 138
Alpha 1 Biomedicals, Inc. - Mar., p. 73; May, p. 131; Sep., p. 264; Dec., p. 357
Amarillo Cell Culture Co. - June, p. 169
American Biogenetic Sciences, Inc. - Oct., p. 296
American Cyanamid Co. (portions acquired in late 1994 by Amer. Home Prod.) - Aug., p. 230; Sep., p. 264
American Home Products Corp. - Feb., p. 33; June, p. 170; Sep., p. 264; Nov., p. 331
American Vaccine Corp. - Feb., p. 39
Amira Inc. - Aug., p. 230
AMRAD Corp. - June, p. 170
Antiretroviral Pregnancy Registry - Aug., p. 227
Anver Bioscience Design, Inc. - Feb., p. 44
Apollon Inc. - Sep., p. 268
Apotex Pharmaceuticals - Feb., p. 41
ARCH Development Corp. - July, p. 206
Army Medical Research and Development Command - Feb., p. 42
Astra AB - Apr., p. 97
ATIS (use HIV/AIDS Treatment Information Service)
Avid Therapeutics Inc. - Mar., p. 74; Apr., p. 103; July, p. 206
Baker Norton Pharmaceuticals, Inc. - Aug., p. 235
Barr Labs. - Oct., p. 300; Dec., p. 364
Baxter International - Sep., p. 268
Bayer AG - Apr., p. 97
Baylor College of Medicine - Apr., p. 103
Beavermade Ltd. - Feb., p. 41
Behring AG - June, p. 172
Behringwerke AG - Feb., p. 39
BIKEN Institute - Feb., p. 35
Bio-Rad Labs. - Dec., p. 362
BioChem Pharma Inc. - Apr., p. 98; June, p. 170; Nov., p. 321, 322, 324; Dec., p. 362
Biocine Corp. (acquired by Chiron in late 1994) - Feb., p. 42; June, p. 168; Aug., p. 233; Oct., p. 300; Nov., p. 324, 326, 328
Bioclones (Pty) Ltd. - Dec., p. 363
Biocontrol Technology, Inc. - Oct., p. 293
Biogen Corp. - Aug., p. 236; Nov., p. 333
Biomedical Research, Inc. - Feb., p. 43
Bioqual, Inc. - Aug., p. 232
BioServe Biotechnologies Ltd. - Sep., p. 267
Biotechnology Information Institute - Mar., p. 75
BioVac (subsidiary of BioChem Pharma Inc.) - June, p. 170
Boehringer Ingelheim Pharmaceuticals, Inc. - Apr., p. 97; Dec., p. 356
Boryung Pharmaceuticals Co. Ltd. - Nov., p. 328
Bristol-Myers Squibb Co. - Feb., p. 34; May, p. 137; June, p. 161, 164, 200, 202; Aug., p. 225; Oct., p. 295; Dec., p. 356
Burroughs Wellcome Co. (see also Wellcome) - Feb., p. 41; Mar., 65; Apr., p. 97, 103; May, p. 135; June, p. 171; July, p. 197; 199; Aug., p. 227; Sep., p. 257; 270; Oct., p. 290; 300; Nov., p. 321; Dec., p. 356; 358; 364
Cambridge Biotech Corp. - May, p. 138; July, p. 202; Dec., p. 359
Cambridge Research Biochemicals - Nov., p. 325
Cantab Pharmaceuticals PLC - Sep., p. 268
Castle Group - July, p. 201
CBR Labs. - Oct., p. 293
CDC National AIDS Treatment Clearinghouse - Nov., p. 332
CEL-SCI Corp. - Nov., p. 331
Celgene Corp. - Apr., p. 102; Oct., p. 297
Cell Genesys, Inc. - July, p. 200, 204
Cellcor, Inc. - Aug., p. 230
Center for Blood Research, Inc. - Oct., p. 293
Center for Special Immunology - Feb., p. 38
Centers for AIDS Research (CFARs) - Apr., p. 104
Centers for Disease Control and Prevention (CDC) - June, p. 170; Aug., p. 227, 233
Centre Nationale de Transfusion Sanguine - Oct., p. 291; Nov., p. 331
China National Biological Products Corp. - Dec., p. 362
Chiron Corp. - Feb., p. 42; June, p. 164, 168; July, p. 194; Aug., p. 233; Sep., p. 267; Oct., p. 300; Nov., p. 324, 326, 328, 330; Dec., p. 366
Chiron Vision Corp. - Dec., p. 353, 363
Chugai Pharmaceutical Co., Ltd. - Aug., p. 232; Sep., p. 267
Chulalongkorn Univ. - June, p. 171
Ciba-Geigy Ltd. - June, p. 168; July, p. 194; Aug., p. 233; Oct., p. 300; Nov., p. 324, 326; Dec., p. 357
Clearinghouse for Networked Information Discovery and Retrieval (CNIDR) - Dec., p. 363
Cleveland Clinic - July, p. 201
Clinical Chemistry Consultants, Inc. - Sep., p. 266
Columbia Univ. - Dec., p. 355
Community Research Initiative on AIDS - Aug., p. 231
Community Research Institute New England - Aug., p. 229
Connaught Labs. (subsidiary of Rhone-Poulenc Rorer) - Mar., p. 73; June, p. 170, 172
CPCRA (use Terry Beirn Community Programs for Clinical Research on AIDS)
Cryopharm Corp. - Sep., p. 265
CTS Chemical Industries - Nov., p. 328
Daiichi Pure Chemicals Co. - Oct., p. 300
Dainabbott Ltd. - Oct., p. 300
Dana-Farber Cancer Inst. - Apr., p. 104
Dartmouth College - Oct., p. 291
Davol Div., C.R. Bard Inc. - Apr., p. 103
Department of Defense - Feb., p. 33
Division of AIDS, NIAID - June, p. 172
DuPont Corp. - Dec., p. 362
DuPont Merck Pharmaceuticals - Feb., p. 40; Apr., p. 97
E. Merck AG - Nov., p. 331
Eisai Co., Ltd. - May, p. 130
Eli Lilly & Co. (use Lilly, Eli & Co.)
Emory Univ. - Mar., p. 74; Apr., p. 103
Epitec Ltd. - June, p. 171
Epitope Corp. - Dec., p. 363
Essex Chemical - Oct., p. 291
European Patent Office - Aug., p. 236
FDA Antiviral Drugs Advisory Committee - June, p. 161; Nov., p. 323
FDA Vaccines and Related Biological Products Advisory Commitee - Feb., p. 35
FDA - Feb., p. 42; Apr., p. 102; June, p. 165; July, p. 197; Sep., p. 259, 261; Nov., p. 331
Federal Trade Commission - Feb., p. 39; Nov., p. 331
Fitzsimmons Army Medical Center - Dec., p. 357
Forest Labs. - Dec., p. 360
Food and Drug Administration (use FDA)
Fox Chase Cancer Center - Mar., p. 74
Fred Hutchinson Cancer Research Center - Mar., p. 75; Sep., p. 268
FujiRebio Pharmaceuticals - Oct., p. 300
GA Investments SA - June, p. 171
Gallo, R.C. - Feb., p. 42
GelTex Pharmaceuticals, Inc. - Nov., p. 332
Gen-Probe Inc. - Sep., p. 267
Genelabs Technologies, Inc. - May, p. 137
Genentech Inc. - June, p. 164; July, p. 194; Dec., p. 359
Genesis Bio Pharmaceuticals - Feb., p. 39
Genetic Therapy, Inc. - May, p. 139
Genetics Institute (majority owned by Amer. Home Prod.) - Feb., p. 36
GenPharm International - July, p. 204
Genta Inc. - Aug., p. 231
Genta Jago Technologies B.V. - Aug., p. 231
Georgetown Univ. - Aug., p. 232
German Red Cross Blood Transfusion Service - Sep., p. 266
Gilead Sciences, Inc. - Feb., p. 40; Mar., p. 71; May, p. 138; Aug., p. 230, 232
Glaxo Holdings PLC - Apr., p. 97, 98; Nov., p. 321, 322
Green Cross Corp. - Apr., p. 102
Grelan Pharmaceutical - Nov., p. 328
Harvard Medical School - Apr., p. 104
Harvard School of Public Health - Mar., p. 67
Haworth Press - May, p. 139
Hayashibara Biochemical Labs. - June, p. 169
Health Professionals, Inc. - Feb., p. 38
Hedral Therapeutics, Inc. - Oct., p. 297
HEM Pharmaceuticals - Dec., p. 363
HemaCare Corp. - Feb., p. 37
HemaSure Inc. - Sep., p. 266
HemoCleanse, Inc. - Oct., p. 293; Dec., p. 362
HIV Vaccine Efficacy Trials Network (HIVNET) - Mar., p. 75
HIV/AIDS Treatment Information Service (ATIS) - Nov., p. 332
Hoechst AG - Apr., p. 97
Hoechst-Roussel - Oct., p. 297
Hoffmann-La Roche Inc. - Feb., p. 34; Mar., p. 73; Apr., p. 97, 102; May, p. 137, 138, 140; Aug., p. 226, 227; Sep., p. 264, 270; Nov., p. 326
Hoffmann-La Roche Ltd. - June, p. 169; Dec., p. 359
Howard Hughes Medical Institute - June, p. 173
Hybridon, Inc. - May, p. 133; July, p. 201; Aug., p. 233; Oct., p. 295
ICN Pharmaceuticals Inc. - June, p. 171; Aug., p. 233
ICOS Corp. - Oct., p. 297
IDC Holdings, Ltd. - Oct., p. 293
IDEXX Corp. - Dec., p. 366
IDT, Inc. - Oct., p. 293
Immune Response Corp. - Mar., p. 72; May, p. 138; June, p. 172; Aug., p. 232
Immunex Corp. - Sep., p. 264
Immunization Products Ltd. - Mar., p. 72; May, p. 138; Aug., p. 232
Immuno AG - Aug., p. 231
Immusol Inc. - Sep., p. 268
INCSTAR Corp. - Mar., p. 74
Institut National de la Sante et de la Recherche Medicale (INSERM) - Oct., p. 293
Institut Pasteur - Apr., p. 102; July, p. 202
Institute for Health Care Business Development - Mar., p. 76
Inter-Company Collaboration for AIDS Drug Development - Apr., p. 97; Sep., p. 261
Interferon Sciences, Inc. - Feb., p. 39; May, p. 140
International Conference on AIDS - Aug., p. 228
Internet - Dec., p. 363
Isis Pharmaceuticals, Inc. - Feb., p. 43; May, p. 130; Aug., p. 233; Nov., p. 325
Istituto Superiore di Santa - Mar., p. 74
Ivax Corp. - Aug., p. 235
Jagotec AG - Aug., p. 231
Japan Tobacco Co., Ltd. - Mar., p. 70; Dec., p. 360
Japanese Foundation for Cancer Research - Feb., p. 41
Japanese Ministry of Health and Welfare - Mar., p. 73; June, p. 169; July, p. 200
John Greenberg Library of Alternative Treatments - Feb., p. 44
Johns Hopkins Univ. School of Medicine - Feb., p. 40; July, p. 202
Johnson & Johnson Co. - Oct., p. 300
Johnson Matthey PLC - Oct., p. 296
JT Immunotech USA - July, p. 204
Kaketsuken - Oct., p. 300
Kyokuto Seiyaku Kogyo Inc. - Oct., p. 300
Lederle Praxis Biologicals - Sep., p. 264
LIDAK Pharmaceuticals - Nov., p. 328
Lilly, Eli & Co. - Feb., p. 36; Apr., p. 97, 102; June, p. 165
Marion Merrell Dow Inc. - Mar., p. 68
Matrix Pharmaceutical, Inc. - Oct., p. 289
Medarex, Inc. - Oct., p. 291; Nov., p. 331
Medeva PLC - Feb., p. 41; Mar., p. 73; June, p. 170, 171; Oct., p. 296; Nov., p. 333
Medical Biology Institute - Nov., p. 328
Medical College of Wisconsin - Apr., p. 100
MediChem Research, Inc. - Apr., p. 106; Sep., p. 270
MedImmune Inc. - July, p. 200; Sep., p. 264; Oct., p. 296
Merck & Co. - Feb., p. 35; Mar., p. 69; Apr., p. 97, 101; May, p. 141; June, p. 172; Dec., p. 362
Merck AG, E. (use E. Merck AG)
Merck Frosst Canada Inc. - Mar., p. 73
Microbiological Associates - Mar., p. 75
MicroGeneSys, Inc. - Feb., p. 33
Miles Inc. - Apr., p. 97
Miles Pharmaceutical - Mar., p. 74
Mochida Pharmaceutical Co., Ltd. - June, p. 169
Monsanto Corp. - Nov., p. 326
Multicenter AIDS Cohort Study - Sep., p. 257
Mundipharma Pharmaceutical Co. - Feb., p. 39
Murex Diagnostics Ltd. - Dec., p. 366
National Cancer Inst. (NCI) - Feb., p. 36; Mar., p. 74; Apr., p. 106; May, p. 129; Aug., p. 235; Dec., p. 364
National Cooperative Drug Discovery Groups - Apr., p. 104; May, p. 139
National Eye Institute (NEI) - Dec., p. 353
National Institute of Allergy and Infectious Diseases (NIAID) - June, p. 164, 172; July, p. 194; Aug., p. 232; Oct., p. 292
National Institute of Mental Health (NIMH) - Oct., p. 301
National Institutes of Health (use NIH)
National Library of Medicine (NLM) - Apr., p. 105
National Organization for Rare Diseases (NORD) - Apr., p. 103
National Task Force on AIDS Drug Development - Feb., p. 42
New England Medical Center - Sep., p. 268
New York Blood Center - Apr., p. 103
New York State Dept. of Health - Oct., p. 297
NIH - June, p. 164; July, p. 202, 205; Aug., p. 235; Sep., p. 267, 270
NIH Office of AIDS Research - Mar., p. 75
NIH Office of Research Integrity - Feb., p. 42
NIH Subcommittee to Review FIAU Studies - June, p. 166
Nippon Shoji Kaisha - July, p. 200
Nippon Zeon Co., Ltd. - Oct., p. 297
North American Biologicals, Inc. - Dec., p. 359
Northfield Labs. - Apr., p. 101
NovaGene Inc. - Apr., p. 103
Novopharm, Inc. - Oct., p. 300; Dec., p. 364
Oclassen Pharmaceuticals, Inc. - June, p. 165
Oregon Health Sciences Univ. - Oct., p. 297
Organetics Ltd. - Oct., p. 293
Organon Teknika Corp. - Dec., p. 363, 366
Ortho Diagnostic Systems Inc. - Oct., p. 300; Dec., p. 366
Otsuka Pharmaceutical Co., Ltd. - May, p. 134; June, p. 169; Oct., p. 300
Oxigene, Inc. - Dec., p. 363
Oxo Chemie GmbH - Dec., p. 359
Parke-Davis (use Warner-Lambert Co.)
Pasteur Merieux Serums et Vaccins (sub. of Rhone-Poulenc Rorer) - Feb., p. 39; Mar., p. 73; June, p. 172; Oct., p. 296
Paul, W.E. - Mar., p. 75
Perkin-Elmer Corp. - Apr., p. 102
Pfizer & Co. - Apr., p. 97
Pierre Fabre Medicaments - June, p. 172
Popovic, M. - Feb., p. 42
Population Council - June, p. 169
PRA Labs - Nov., p. 331
Procept Inc. - Apr., p. 104; Nov., p. 330
Progenics Pharmaceuticals, Inc. - Feb., p. 43; Apr., p. 104; Nov., p. 332
Proteus International PLC - Feb., p. 41; Mar., p. 73
Purdue Frederick Co. - Feb., p. 39
Repligen Corp. - Aug., p. 230
Rhone-Poulenc Rorer - Feb., p. 39; Mar., p. 72; May, p. 138; June, p. 172; Aug., p. 232; Oct., p. 296
Ribi ImmunoChem Research, Inc. - Nov., p. 327, 328
RiboGene, Inc. - Sep., p. 269
Ribozyme Pharmaceuticals, Inc. - Sep., p. 267
Roche Holding Ltd. - May, p. 138
Rockefeller Univ. - Oct., p. 297
San Francisco General Hospital - Nov., p. 330
Sandoz AG - Oct., p. 296
Schering-Plough K.K. - Mar., p. 73; June, p. 169
SciClone Pharmaceuticals, Inc. - May, p. 131; Sep., p. 264; Dec., p. 357
Sclavo SpA (acquired by Ciba-Geigy Ltd.) - Feb., p. 42; Dec., p. 357
Scripps Research Inst. - Mar., p. 72
SEARCH Alliance - Aug., p. 229
Searle, G.D. & Co. - Nov., p. 326
Seragen, Inc. - Feb., p. 41
Shaman Pharmaceuticals, Inc. - Dec., p. 360
Shanghai Institute of Biological Products - Dec., p. 362
Sheffield Medical Technologies Inc. - Oct., p. 293
Sigma-Tau S.p.A. - Apr., p. 97
Sloan-Kettering Memorial Cancer Inst. - May, p. 140
SmithKline Beecham Biologicals - Nov., p. 327; Dec., p. 362
SmithKline Beecham Corp. - Feb., p. 35, 39, 40; Apr., p. 97, 106; July, p. 193; Sep., p. 270; Nov., p. 325
South Australia government - Apr., p. 101
SPI Pharmaceuticals - Aug., p. 233
SRL, Inc. - Aug., p. 230
St. Vincent's Hospital (Sidney, Australia) - Oct., p. 295
Stanford Univ. - Sep., p. 268
Storz Instrument Co. - Aug., p. 230
Strategic Program for Innovative Research on AIDS Treatment (SPIRAT) - Sep., p. 268
Swiss Serum and Vaccine Institute - Feb., p. 39
Sylka Managing Co. Inc. - Nov., p. 329
Synbiotics Corp. - Dec., p. 366
Syntello Vaccine Development - Mar., p. 77
Syntex Corp. (acquired in late 1994 by Hoffmann-La Roche) - Apr., p. 97, 103; May, p. 138; Aug., p. 227; Sep., p. 264; Oct., p. 297; Nov., p. 328
SyStemix, Inc. - Nov., p. 325
T Cell Diagnostics, Inc. - Mar., p. 74
TargeTech, Inc. - Aug., p. 232
Targeted Genetics Corp. - Sep., p. 268, 270
Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) - Sep., p. 269
Teva Pharmaceuticals - Feb., p. 41
Therion Biologics Corp. - Mar., p. 71; Apr., p. 104; Sep., p. 262; Nov., p. 326
Treatment Activist Group - Mar., p. 73; Sep., p. 259
Tularik, Inc. - Apr., p. 101
U.K. Herpes Association - June, p. 171
U.S. Army Medical Research and Development Command - Nov., p. 332
U.S. Bioscience, Inc. - June, p. 174
U.S. Congress - Apr., p. 103
U.S. Court of Appeals for the Federal Circuit - Dec., p. 364
U.S. Dept. of Agriculture (USDA) - Oct., p. 297
United Biomedical, Inc. - June, p. 171, 201; Sep., p. 268; Oct., p. 300
Univ. of Alabama - July, p. 201, 204
Univ. of California (San Diego, CA) - Sep., p. 268; Nov., p. 330
Univ. of California - Apr., p. 100; May, p. 132; Dec., p. 366
Univ. of Colorado Health Science Center - May, p. 139
Univ. of Georgia - Sep., p. 265
Univ. of Gothenburg - Mar., p. 77
Univ. of Illinois at Chicago - Apr., p. 106
Univ. of North Carolina - Sep., p. 267
Univ. of Pennsylvania - Sep., p. 268
Univ. of Southern California - Dec., p. 359
Univ. of Washington - Mar., p. 75
Upjohn Co. - May, p. 138; July, p. 199; Oct., p. 296
Varmus, H. - Feb., p. 40
Verex Laboratories Inc. - Dec., p. 358
Verigen Inc. - Feb., p. 38
Vestar Inc. - Nov., p. 330
Viagene, Inc. - Apr., p. 102; Sep., p. 267; Nov., p. 330; Dec., p. 361
Vical Inc. - May, p. 139, 141; Oct., p. 296; Nov., p. 330
VIMRx Pharmaceuticals Inc. - Apr., p. 103
Viratek Inc. - June, p. 171; Aug., p. 233
Virotech Inc. - Oct., p. 293
VZV Research Foundation - Nov., p. 332
W.R. Grace & Co. - Nov., p. 332
Walter Reed Army Inst. of Research (WRAIR) - Feb., p. 33; Nov., p. 324, 328; Dec., p. 357
Warner Wellcome Consumer Health - Feb., p. 41
Warner-Lambert Co. - Feb., p. 40, 41; June, p. 170; July, p. 206
Washington Adventist Hospital - Sep., p. 267
Washington Hospital Center - Sep., p. 267
Wellcome Foundation - Feb., p. 41
Wellcome PLC (see also Burroughs Wellcome Co.) - Apr., p. 98; July, p. 202
Western Australia - June, p. 170
WHO Global Programme on AIDS - Nov., p. 324
Wistar Institute - Feb., p. 36
Wyeth-Ayerst Pharmaceuticals - June, p. 170
Xenotech, L.P. - July, p. 204
Yamanouchi Europe - Nov., p. 328
Yamanouchi Pharmaceutical Co., Ltd. - June, p. 169
Yamasa Corp. - July, p. 200
Zeneca Ltd. - Nov., p. 325